These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34830047)

  • 1. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
    Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Fei F; Zhang M; Tarighat SS; Joo EJ; Yang L; Heisterkamp N
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008.
    Paz H; Joo EJ; Chou CH; Fei F; Mayo KH; Abdel-Azim H; Ghazarian H; Groffen J; Heisterkamp N
    J Exp Clin Cancer Res; 2018 Mar; 37(1):67. PubMed ID: 29580262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3.
    Fei F; Joo EJ; Tarighat SS; Schiffer I; Paz H; Fabbri M; Abdel-Azim H; Groffen J; Heisterkamp N
    Oncotarget; 2015 May; 6(13):11378-94. PubMed ID: 25869099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia.
    Bum-Erdene K; Collins PM; Hugo MW; Tarighat SS; Fei F; Kishor C; Leffler H; Nilsson UJ; Groffen J; Grice ID; Heisterkamp N; Blanchard H
    J Med Chem; 2022 Apr; 65(8):5975-5989. PubMed ID: 35427125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells.
    Kihira K; Chelakkot VS; Kainuma H; Okumura Y; Tsuboya N; Okamura S; Kurihara K; Iwamoto S; Komada Y; Hori H
    Int J Hematol; 2020 Dec; 112(6):795-806. PubMed ID: 32862292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
    Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence.
    Luong A; Cerignoli F; Abassi Y; Heisterkamp N; Abdel-Azim H
    PLoS One; 2021; 16(9):e0258140. PubMed ID: 34591931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell precursor acute lymphoblastic leukemia elicits an interferon-α/β response in bone marrow-derived mesenchymal stroma.
    Smeets MWE; Steeghs EMP; Orsel J; Stalpers F; Vermeeren MMP; Veltman CHJ; Slenders L; Nierkens S; Van de Ven C; Den Boer ML
    Haematologica; 2024 Jul; 109(7):2073-2084. PubMed ID: 38426282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.
    Buske C; Becker D; Feuring-Buske M; Hannig H; Wulf G; Schäfer C; Hiddemann W; Wörmann B
    Leukemia; 1997 Mar; 11(3):386-92. PubMed ID: 9067578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion.
    Yu K; Wang J; Lu T; Ma D; Wei D; Guo Y; Cheng B; Wang W; Fang Q
    J Cell Biochem; 2019 Oct; 120(10):17791-17810. PubMed ID: 31264739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.
    Stamatopoulos B; Meuleman N; De Bruyn C; Pieters K; Mineur P; Le Roy C; Saint-Georges S; Varin-Blank N; Cymbalista F; Bron D; Lagneaux L
    Haematologica; 2012 Apr; 97(4):608-15. PubMed ID: 22058221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment.
    Polak R; de Rooij B; Pieters R; den Boer ML
    Blood; 2015 Nov; 126(21):2404-14. PubMed ID: 26297738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4.
    Yu K; Yin Y; Ma D; Lu T; Wei D; Xiong J; Zhou Z; Zhang T; Zhang S; Fang Q; Wang J
    Int Immunopharmacol; 2020 Mar; 80():106008. PubMed ID: 31978797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
    Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
    Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients.
    Traxel S; Schadt L; Eyer T; Mordasini V; Gysin C; Munthe LA; Niggli F; Nadal D; Bürgler S
    Oncogene; 2019 Mar; 38(13):2420-2431. PubMed ID: 30532071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.
    Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of exosomes derived from B-cell acute lymphoblastic leukemia as a growth factor on bone marrow mesenchymal stromal cells.
    Amirpour M; Kuhestani-Dehaghi B; Kheyrandish S; Hajipirloo LK; Khaffafpour Z; Keshavarz F; Allahbakhshian-Farsani M
    Mol Biol Rep; 2024 Jun; 51(1):749. PubMed ID: 38874800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy.
    Pramanik R; Sheng X; Ichihara B; Heisterkamp N; Mittelman SD
    Leuk Res; 2013 May; 37(5):503-9. PubMed ID: 23332453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.
    Huang M; Inukai T; Miyake K; Tanaka Y; Kagami K; Abe M; Goto H; Minegishi M; Iwamoto S; Sugihara E; Watanabe A; Somazu S; Shinohara T; Oshiro H; Akahane K; Goi K; Sugita K
    Cancer Med; 2018 Apr; 7(4):1297-1316. PubMed ID: 29473342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.